<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02621307</url>
  </required_header>
  <id_info>
    <org_study_id>GLUSEED</org_study_id>
    <nct_id>NCT02621307</nct_id>
  </id_info>
  <brief_title>Effect of Salba &amp; Flax on Postprandial Glycemia and Subjective Satiety</brief_title>
  <official_title>The Effect of Salba (Salvia Hispanica L) Versus Flax on Postprandial Blood Glucose Response and Subjective Appetite in Healthy Individuals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Michael's Hospital, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Michael's Hospital, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether drinks containing Salvia hispanica L
      (Salba) or Flax lower postprandial blood glucose levels and improve appetite in healthy
      individuals.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Dietary fibre has been implicated in improving many risk factors associated with Type 2
      Diabetes and Cardiovascular Disease (CVD). However, on average, Norther Americans consume
      less than half of the recommended amount set by health agencies. It has been proposed that
      the health benefits of dietary fibre may be attritbuted to rheological characteristics such
      as viscosity. Salvia hispanica L (Salba) and Flax are nutritionally similar. The primary
      objective of this research trial is to study the effects of Salba and Flax on postprandial
      glycemia and appetite in healthy individuals.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Postprandial Blood Glucose</measure>
    <time_frame>2 Hours</time_frame>
    <description>At each visit, postprandial blood glucose will be measured via capillary blood samples, at 15, 30, 45, 60, 90, and 120 minutes after intake of test meals</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Subjective Satiety</measure>
    <time_frame>2 Hours</time_frame>
    <description>At each visit, subjective satiety (how hungry/full you feel) will be measured via questionnaires, at 15, 30, 45, 60, 90, and 120 minutes after intake of test meals</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Hyperglycemia, Postprandial</condition>
  <arm_group>
    <arm_group_label>Salba</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>50g glucose 25g ground Salba (Salba Corporation Ltd, Buenos Aires, Argentina) 200ml water</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Flax</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>50g glucose 31g ground Flax (Bob's Red Mill Natural Raw Whole Flaxseed) 200ml water</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>50g glucose 200ml water</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Salba</intervention_name>
    <arm_group_label>Salba</arm_group_label>
    <other_name>Salvia hispanica L</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Flax</intervention_name>
    <arm_group_label>Flax</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Control</intervention_name>
    <arm_group_label>Control</arm_group_label>
    <other_name>Glucose</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI less than 35 kg/m^2

        Exclusion Criteria:

          -  known history of liver or kidney disease, diabetes, hypertension, stroke, or
             myocardial infarctions, thyroid disease, gastrointestinal disease, or AIDS

          -  subjects using medications or Natural Health Products
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>St. Michael's Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5B 1W8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 27, 2015</study_first_submitted>
  <study_first_submitted_qc>December 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 3, 2015</study_first_posted>
  <last_update_submitted>December 1, 2015</last_update_submitted>
  <last_update_submitted_qc>December 1, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Michael's Hospital, Toronto</investigator_affiliation>
    <investigator_full_name>Vladimir Vuksan</investigator_full_name>
    <investigator_title>Research Scientist &amp; Professor</investigator_title>
  </responsible_party>
  <keyword>postprandial glycemia</keyword>
  <keyword>subjective appetite</keyword>
  <keyword>Salba</keyword>
  <keyword>Flax</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

